Simple Summary The advancement of nanotechnology over the last three decades has
given new hope to cancer management. The first FDA-approved nanomedicine (DOXIL) was …

Lung cancer accounts for a relatively high proportion of malignant tumors. As the most
prevalent type of lung cancer, non-small cell lung cancer (NSCLC) is characterized by high …

Doxorubicin (DOX) is a chemotherapy drug used for hepatocellular carcinoma (HCC)
treatment, but its effectiveness can be dramatically dampened by cancer cell …

Despite the existence of several treatment modalities and advancements in cancer research,
brain cancer is still incurable. Over-expression of nucleolin receptors on cancer cells has …

Nanomedicine application in cancer therapy is an urgency because of inability of current
biological therapies for complete removal of tumor cells. The development of smart and …

With the accelerated development of nanotechnology in recent years, nanomaterials have
become increasingly prevalent in the medical field. The poly (lactic acid–glycolic acid) …

Lung cancer, the second leading cause of cancer-related mortality and incidence globally,
presents a formidable challenge with an estimated 238,340 new cases and 127,070 deaths …

The site-specific delivery of drugs, especially anti-cancer drugs has been an interesting field
for researchers and the reason is low accumulation of cytotoxic drugs in cancer cells …

Cancer has emerged as a significant threat that gravely endanger human health. Anti‐tumor
immunotherapy has now emerged as an important treatment for cancer. However …

There have been great advancements in targeted nanodrug delivery systems for tumor
therapy. Liposomes, polymeric nanoparticles, and inorganic nanoparticles are commonly …